Navigation Links
Pharmatech Oncology Receives Phase 2 SBIR Funding for Just-In-Time Enrollment Model
Date:8/9/2012

DENVER, Aug. 9, 2012 /PRNewswire/ -- Pharmatech Oncology announces the award of its phase 2 Small Business Innovative Research (SBIR) project, entitled A Patient Centered Approach to Enrolling Rare Cancer Patients in Clinical Trials, to be funded through the National Cancer Institute (NCI).

Pharmatech Oncology has developed an innovative enrollment methodology called Just-In-Time (JIT) to improve enrollment rates into cancer clinical trials, which often see significant delays due to slow patient enrollment.  The major challenge in developing more effective anti-cancer drugs is the time it takes to complete clinical trials demonstrating the safety and efficacy of investigational new drugs. With only an estimated 3 to 5 percent of adult cancer patients participating in clinical trials, and potentially even fewer being offered the opportunity, JIT provides patients with on-demand access to cancer clinical trials and investigational treatments.

In Phase 1 of the SBIR project, Pharmatech Oncology demonstrated that cancer trial enrollment rates can be increased by making specific clinical trials available to a network of research ready centers (Click this link to see the abstract: http://intl-dij.sagepub.com/content/46/4/472.abstract). The JIT enrollment model puts patients first in the research process, prioritizing selection of the most appropriate therapy, and utilizing highly efficient workflow to enroll individual cancer patients into a trial in 10 days or less.

The Phase 2 project addresses the scalability of the JIT enrollment methodology as an industry-wide solution, but even more exciting is its focus on aligning patient genetic and molecular characteristics with personalized therapy. The principal investigator of the project, Dr. Matthew Wiener, believes, "The JIT enrollment methodology is ideally positioned to support the development of targeted cancer m
'/>"/>

SOURCE Pharmatech Oncology, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. WuXi PharmaTech Announces First-Quarter 2012 Results
2. Industry Leading Pharmaceutical News Website in-Pharmatechnologist.com Refocused and Relaunched
3. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
4. Champions Oncology Reports Resignation Of Director
5. Center for Medicare & Medicaid Innovation Awards $19 Million Grant to Develop Oncology Medical Home Model
6. Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities
7. Radiation Therapy in Oncology Drug Pipeline Update 2012
8. Medical Oncology Association of Southern California Purchasing Network (MPN) Names Cardinal Health Specialty Solutions as its Primary Healthcare Solutions Partner
9. Schulman Associates IRB offers oncology-focused review board
10. Debiopharm and Ascepion Pharmaceuticals, Inc. Announce an Exclusive License Agreement for the Development and Commercialisation of the Dual-Targeting Kinase Inhibitor, ASP-08126 (Debio 1144), for the Treatment of Oncology Diseases
11. Velos, Inc. Introduces Mobile App for Oncology Adverse Events and Graft-Versus-Host Disease at 2012 ASCO Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Inc. (NASDAQ: VRML ), a bio-analytical solutions company ... the 27 th Annual ROTH Conference, which is being ... from March 8 to March 11. ... will be presenting on Monday, March 9 at 12:00 noon ... the company,s Vice President of Finance and Chief Accounting Officer. ...
(Date:3/3/2015)... Fla. , March 3, 2015 ... pleased to announce the hiring of Brian ... to lead business development efforts and build relationships ... of experience in software development, sales, and sales ... enterprise software applications. iTraycer is a comprehensive inventory ...
(Date:3/3/2015)... March 3, 2015  Cumberland Pharmaceuticals Inc. (NASDAQ: ... on hospital acute care and gastroenterology, today announced ... developments include top-line results from the Company,s Hepatoren ... Drug Application (sNDA) with pediatric data for Caldolor ... Phase II clinical trial. "The sNDA ...
Breaking Medicine Technology:Vermillion To Present at 27th Annual ROTH Conference on March 9 2Medical Tracking Solutions, Inc. Hires New SVP, Sales 2Cumberland Pharmaceuticals Reports Clinical And Regulatory Milestones 2Cumberland Pharmaceuticals Reports Clinical And Regulatory Milestones 3Cumberland Pharmaceuticals Reports Clinical And Regulatory Milestones 4Cumberland Pharmaceuticals Reports Clinical And Regulatory Milestones 5
... The Global Genes Project ( www.globalgenesproject.org ), ... awareness about the prevalence of rare diseases worldwide, ... The 7,000 Bracelets for Hope™ campaign is designed ... chronic, life-threatening and fatal rare diseases and disorders ...
... SEATTLE, Nov. 1, 2010 Cell Therapeutics, Inc. ... it has submitted a Marketing Authorization Application ("MAA") ... (pixantrone dimaleate) as monotherapy for the treatment of ... non-Hodgkin,s lymphoma ("NHL"). The application submission follows a ...
Cached Medicine Technology:7,000 Bracelets For Hope™ - A Rare Disease Awareness Campaign 27,000 Bracelets For Hope™ - A Rare Disease Awareness Campaign 3Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for Pixuvri® 2Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for Pixuvri® 3
(Date:3/3/2015)... The report “Alopecia – Pipeline Review, H1 2015? ... Alopecia is the loss of hair. Alopecia areata and ... Causes for alopecia include aging, genetics, illness, chemotherapy, malnutrition ... pattern hair loss, female diffuse hair loss, hairs easily ... focal or diffuse and by the presence or absence ...
(Date:3/3/2015)... 03, 2015 US Air Purifiers LLC ... purification systems, is pleased to announce that all Rabbit brand ... interruption related to the west coast port strikes. This news ... the corner. , The port strikes, which ... slow fourth quarter economic growth by as much as 1%, ...
(Date:3/3/2015)... Daylight Savings Time may lead to your kids to ... parents. , Parents and their children may feel a bit ... set their clocks forward one hour for Daylight Savings Time. ... hour earlier -- you will have already lost one hour ... “sleep hygiene” for their kids and teens this week, says ...
(Date:3/3/2015)... Rhinebeck, NY (PRWEB) March 03, 2015 Topical ... held as a webinar streamed live on Tuesday, March 10th, ... workshops will be archived and accessible 24/7. ... the public. The topic for the March 10th workshop is ... timely discussion, considering that the U.S. represents 5% of the ...
(Date:3/3/2015)... Today is International Ear Care Day, ... occasion to applaud and promote the launch of Make ... Organization (WHO) for stemming the threat of noise-induced hearing ... people to practice safe listening when they recreate, be ... sporting events, or engaging in other forms of entertainment. ...
Breaking Medicine News(10 mins):Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 4Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 2Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 3Health News:Don’t Let Daylight Savings Disrupt Your Child’s Sleep 2Health News:Topical BioMedics Hosts March Pain Management Webinar 2Health News:Topical BioMedics Hosts March Pain Management Webinar 3Health News:Topical BioMedics Hosts March Pain Management Webinar 4Health News:Topical BioMedics Hosts March Pain Management Webinar 5Health News:ASHA Applauds Launch of New WHO Campaign 2
... epidemic proportions in Gujarat according to the government there ... any part of flood-ravaged Surat.// ,Quoting the ... State Health Secretary Amarjit Singh, Delhi, said that all ... rodent samples for plague as well as for Hantavirus ...
... has ordered administrations of all 30 districts to collect Pepsi ... ,The officials were Thursday asked to send the ... department official. ,These would then be sent to ... not have testing facilities to confirm the presence of pesticides. ...
... the time that kids spend in exercise will not guarantee ... //Economist John Cawley of Cornell University and colleagues found in ... students taking part in physical education decreased from 42% in ... data on 37,000 teens in grades nine through 12. All ...
... highly sensitive to allergies in the first three years of ... ,Sabina Illi and colleagues at the University Children's Hospital, Munich, ... allergens in early life and the effect of the sensitization ... They had reported their findings in the latest issue of ...
... with their doctors and practice nurses every year, according to ... revealed that over 11 million appointments with the doctors were ... in UK last year. The problem is more prevalent in ... Midlands are just behind. The survey was conducted among 329 ...
... that a specific variety of adult stem ... or other// types of tissue depending on the response ... researchers found that mesenchymal stem cells, which are commonly ... from their local environment, allowing a transformation into different ...
Cached Medicine News:Health News:Babies Prone To Allergies More likely To Be Asthmatic 2Health News:Adult stem cells are sensitive to responses from the environment 2
With BareWire technology, the wire crosses the lesion first, independent of the filter and delivery catheter. All other actions, including filter placement and retrieval, balloon dilatations, and ste...
... been uniquely designed to fit the ... integrated networks spanning multi-facilities. From test ... and accounts receivable, Centricity Ultra facilitates ... All system modules are fully integrated ...
... IMMULITE 2500 is a high-throughput immunoassay ... ,of the IMMULITE 2000 with the important ... technology ,allows assays to be designed for ... times. ,This allows for critical assays such ...
... Dehydroepiandrosterone sulfate (DHEA-S) is the sulfate ester ... by enzymatic conversion of DHEA in adrenal ... C19 steroid secreted by the adrenal cortex, ... estrogen biosynthesis. DHEA possesses relatively weak androgenic ...
Medicine Products: